Hartford AAA CLO ETF (TRPA)
Live price chart, market sentiment, and community perspectives for Hartford AAA CLO ETF (CBOE: TRPA).
Live price chart, market sentiment, and community perspectives for Hartford AAA CLO ETF (CBOE: TRPA).
On our desk, looking at TRPA's price action, we notice an extremely tight trading band hugging the $38.92 level for both the 50-day and 200-day moving averages. With a 52-week range spanning just from $38.44 to $39.35, the asset behaves much like a cash equivalent or ultra-short duration vehicle. Public sentiment might lean mildly defensive at 56%, but market action shows very little actual panic or aggressive selling.
Reviewing the structural changes from Wellington and Hartford, the fund's objective shift effective February 2024 to prioritize high-quality AAA-rated collateralized loan obligations has created a very stable income profile. Even though Macroaxis flags a conservative 'Sell' model output on a 90-day horizon, the underlying asset class has maintained its strong historical reputation for capital preservation.
From an institutional ownership perspective, Q2 2026 filings show 26 funds holding $86M out of the $111M total AUM. We saw 6 new positions opened and 10 increased, which balances out the 9 reductions and 6 exits. This steady institutional foot traffic indicates that professional allocators view TRPA as a reliable parking spot for yield rather than a tactical trading vehicle.
Watching the short interest data for TRPA, the numbers dropped significantly by 45.4% down to just 6,008 shares at the end of June 2026. With only about 0.2% of shares sold short and a days-to-cover ratio sitting near 0.7 days, short sellers have practically abandoned any bearish bets against this ETF, removing potential squeeze catalysts but also confirming quiet market acceptance.
Analyzing the sentiment disconnect for TRPA, about 50% of the news tone is mixed, and roughly 56% of recent sentiment leans mildly defensive. When quantitative models signal a 'Sell' while the price remains pinned stably near $38.98, it usually highlights a conservative macro posture toward fixed-income securitizations rather than any fundamental operational distress within the portfolio itself.
Explore plasma cleansing, somatic organ swaps, and BCI.